Tirzepatide - Research Peptide

Tirzepatide – Research Peptide

Product Name: Tirzepatide
CAS Number: 2023788-19-2
Molecular Formula: C225H348N48O68
Molecular Weight: ~4813.5 g/mol
Purity: ≥98% (HPLC)
Form: Lyophilized Powder
Storage: -20°C; store in a cool, dry place away from light and moisture

Description:

Tirzepatide is a synthetic peptide designed as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In preclinical and laboratory research settings, Tirzepatide is being studied for its potential to modulate metabolic activity, including glucose regulation, insulin sensitivity, and lipid metabolism.

Research areas include:

Metabolic pathway modulation: Evaluation of GLP-1 and GIP receptor activity in experimental models

Weight regulation: Studies on appetite suppression and energy expenditure in animal subjects

Insulin sensitivity: Investigation of insulin signaling mechanisms and glucose tolerance

Dual agonist pharmacodynamics: Comparison with monoagonist compounds in lab-based assays

Tirzepatide is highly specific and stable under controlled lab conditions, making it a valuable tool in the study of metabolic and endocrine pathways.

Intended Use:
This product is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use, and not to be used in diagnostics, therapeutics, or as a dietary supplement. For use only by qualified personnel in appropriate research facilities.

Disclaimer:
Tirzepatide is sold as a research chemical. It is not a drug, not for human consumption, and not to be administered to humans or animals. All research must comply with applicable laws and safety regulations. For research use only.